| abstract |
In a test method for diagnosing the presence or absence of a WT1-related disease such as leukemia, solid cancer, atypia, and more easily and reliably detecting the progress and prognosis of the treatment, the amount of antibody against WT1 in the sample is measured. Provided is a method for testing a WT1-related disease, wherein the measured value and the change over time are used as clinical indicators in the test. |